Armata Pharmaceuticals

$4.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.66 (-12.82%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell ARMP and other stocks, options, and ETFs commission-free!

About ARMP

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA. The listed name for ARMP is Armata Pharmaceuticals, Inc. Common Stock.

CEO
Todd R. Patrick
Employees
38
Headquarters
Los Angeles, California
Founded
2019
Market Cap
100.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
38.34K
High Today
$5.26
Low Today
$4.28
Open Price
$5.05
Volume
56.99K
52 Week High
$10.48
52 Week Low
$2.52

ARMP Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, After Hours

You May Also Like

KPCPY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure